Patent ID: 6835753
Filing Date: 2004-12-28
Classification: A61K,A61P,Y02A

Abstract:
A method for inhibiting Fc receptor binding of immunoglobulin in a patient comprising administering to such patient a pharmaceutically effective amount of a compound of the formula: or salts thereof, whereinW1 and W2 are independently CO2R3, C(&boxH;NH)NH(OH), PO(OR3)2 or C(&boxH;O)CF3, and at least one of W1 and W2 is CO2R3; each of R1 and R2 is a bond, CH2 or C1-C6 alkylene; each of Ar1 and A2 is independently a C5-C20 aryl; L is a linker selected from the group consisting of a methoxy, C2-C20 alkoxy, and C6-C20 aryl; and, R3 is hydrogen or C1-C6 alkyl.